
Johnson & Johnson Legal Exploit Spurs Congressional Reaction, Legislation
Johnson & Johnson Uses Legal Exploit to Evade Talc Asbestos Liability
Well, they did it. To anyone who was hoping that the corporation once revered as one of the world’s most trusted and wholesome names in healthcare goods would abandon a plan so sinister that it drew criticism even at its mere mention, Johnson & Johnson would like you to know that your hope was woefully misplaced.
When reports surfaced ...
continue reading...Professor Uses End of Life to Educate Women About Ovarian Cancer

By May – four months after the initial conversation – an exam led a ...
continue reading...$2 Billion Johnson & Johnson Talc Cancer Verdict Stands
The fight over a $2 billion talc asbestos cancer verdict that has raged since 2018 has finally come to an end as the United States Supreme Court upheld a Missouri Supreme Court decision. The lawsuit was originally brought by 22 women who alleged that asbestos present in Johnson & Johnson’s talc-based products caused them to develop ovarian cancer.
An exhaustive amount of evidence and testimony has been ...
continue reading...Johnson & Johnson Loses $2.2 Billion Talc Asbestos Appeal
The Missouri Supreme Court declined to overturn a June 23 state appeals court decision that itself had allowed a July 2018 multi-billion dollar verdict to stand against Johnson & Johnson. The company was found liable for 22 women’s development of ovarian cancer. The diagnoses were argued to be the result of the presence of asbestos fibers in talc powder; an allegation long-since ...
Multibillion Dollar Talc Award Cut, but Verdict Stands
It was the sixth largest financial award in the history of the country’s legal system. And while it has been cut in half by a Missouri appeals court, its implications for ongoing talc litigation are significant.
When a St. Louis jury awarded 22 women over $4.5 billion after finding that asbestos present in Johnson & Johnson talc-based hygiene products like Shower to Shower was responsible for their development of ovarian cancer, ...
continue reading...